
Oramed Pharmaceuticals Inc. (ORMP) earnings
- Healthcare
- NASDAQ
- Market cap$155M
Latest result
9 days ago0.0%EPS Inline
2026-11-12Q3 FY2026
- EPS
- Reported / estimate0.43 / 0.43
Stock reaction
Unavailable
Next report
No scheduled report date right now.
Recent quarters
Latest 12 quarters| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-11-12 | 0.43 / 0.43 0.0% | — / — | Unavailable |
Q2 FY2026 2026-08-10 | 2.76 / 0.43 +541.9%‡¶ | — / — | Unavailable |
Q1 FY2026 2026-05-19 | -0.16 / — — | — / — | Unavailable |
Q4 FY2025 2026-03-26 | -0.06 / -0.08 +$0.02*¶ | — / $500K | Unavailable |
Q3 FY2025 2025-11-13 | 1.13 / -0.04 +$1.17*¶ | — / — | Unavailable |
Q2 FY2025 2025-08-14 | -0.05 / -0.04 -$0.01*¶ | — / — | Unavailable |
Q1 FY2025 2025-05-15 | -0.19 / -0.03 -$0.16*¶ | $2.00M / — | Unavailable |
Q4 FY2024 2025-03-27 | 0.01 / -0.03 +$0.04*¶ | — / — | Unavailable |
Q3 FY2024 2024-11-07 | -0.48 / -0.00 -$0.48*¶ | — / — | Unavailable |
Q2 FY2024 2024-08-14 | 0.26 / 0.01 +$0.25*¶ | — / $250K | Unavailable |
Q1 FY2024 2024-05-09 | 0.04 / 0.02 +$0.02*¶ | — / $500K | Unavailable |
Q4 FY2023 2024-03-06 | -0.08 / -0.12 +33.3%¶ | — / — | Unavailable |
Reported / estimate
- Q3 FY2026 · 2026-11-12UnavailableEPS0.43 / 0.430.0%Revenue— / —
- Q2 FY2026 · 2026-08-10UnavailableEPS2.76 / 0.43+541.9%‡¶Revenue— / —
- Q1 FY2026 · 2026-05-19UnavailableEPS-0.16 / ——Revenue— / —
- Q4 FY2025 · 2026-03-26UnavailableEPS-0.06 / -0.08+$0.02*¶Revenue— / $500K
- Q3 FY2025 · 2025-11-13UnavailableEPS1.13 / -0.04+$1.17*¶Revenue— / —
- Q2 FY2025 · 2025-08-14UnavailableEPS-0.05 / -0.04-$0.01*¶Revenue— / —
- Q1 FY2025 · 2025-05-15UnavailableEPS-0.19 / -0.03-$0.16*¶Revenue$2.00M / —
- Q4 FY2024 · 2025-03-27UnavailableEPS0.01 / -0.03+$0.04*¶Revenue— / —
- Q3 FY2024 · 2024-11-07UnavailableEPS-0.48 / -0.00-$0.48*¶Revenue— / —
- Q2 FY2024 · 2024-08-14UnavailableEPS0.26 / 0.01+$0.25*¶Revenue— / $250K
- Q1 FY2024 · 2024-05-09UnavailableEPS0.04 / 0.02+$0.02*¶Revenue— / $500K
- Q4 FY2023 · 2024-03-06UnavailableEPS-0.08 / -0.12+33.3%¶Revenue— / —
- ‡A surprise beyond ±100% is usually a one-off item or a different basis, so it is left out of averages
- *The estimate is under $0.10, so a percentage misleads; the gap is shown in dollars
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.